Search

Displaying results 7151 - 7160 of 8468 in total
  1. Drug

    Morphine glucuronide

    go.drugbank.com/drugs/DB06409
    Investigational

  2. Drug

    RPI-78M

    go.drugbank.com/drugs/DB05740
    Experimental

    RPI-78M is being developed for the treatment of multiple sclerosis (MS). Other neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and amyotrophic lateral sclerosis (ALS).

  3. Drug

    Radotinib

    go.drugbank.com/drugs/DB12323
    Investigational

    Radotinib is under investigation for the treatment of Leukemia, Myelogenous, Chronic, BCR-ABL Positive.

  4. Drug

    BL-1020

    go.drugbank.com/drugs/DB05687
    Investigational

    BL-1020 is a first in class novel compound for the treatment of schizophrenia. It is being developed by BioLineRx (BioLine).

  5. Drug

    D-Tryptophan

    go.drugbank.com/drugs/DB03225
    Experimental

    Tryptophan is one of the 20 standard amino acids, as well as an essential amino acid in the human diet. It is encoded in the standard genetic code as the codon UGG. … It is an essential amino acid as defined by its growth effects on rats.

  6. Drug

    GW 468816

    go.drugbank.com/drugs/DB05417
    Investigational

    It was undergoing phase II trials since December 2003.

  7. Drug

    Pizuglanstat

    go.drugbank.com/drugs/DB19483
    Experimental

    Pizuglanstat has a monoisotopic molecular weight of 508.28 Da.

  8. Drug

    Tolboxane

    go.drugbank.com/drugs/DB19778
    Experimental

    Tolboxane has a monoisotopic molecular weight of 232.16 Da.

  9. Drug

    Afacifenacin

    go.drugbank.com/drugs/DB21385
    Experimental

    Afacifenacin has a monoisotopic molecular weight of 481.2 Da.

  10. Drug

    Fosifidancitinib

    go.drugbank.com/drugs/DB21462
    Experimental

    Fosifidancitinib has a monoisotopic molecular weight of 505.12 Da.